MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
about
MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
MK2206 enhances the cytocidal ...... hibiting the AKT/mTOR pathway.
@en
type
label
MK2206 enhances the cytocidal ...... hibiting the AKT/mTOR pathway.
@en
prefLabel
MK2206 enhances the cytocidal ...... hibiting the AKT/mTOR pathway.
@en
P2093
P2860
P356
P1476
MK2206 enhances the cytocidal ...... hibiting the AKT/mTOR pathway.
@en
P2093
Jun-Min Li
Ru-Fang Xiang
Wen-Bin Xu
Ying-Li Wu
P2860
P2888
P356
10.1038/CDDIS.2017.188
P577
2017-05-11T00:00:00Z
P6179
1085394261